Pediatrix Medical (MD) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.63
- EPS estimate
- $0.59
- EPS surprise
- +6.60%
- Revenue surprise
- +1.94%
- Revenue
- $487.8M
- Revenue estimate
- $478.5M
- Reported
- Aug 4, 2026
Pediatrix reported Q2 2026 results on August 4, 2026. Earnings per share came in at $0.63, ahead of the $0.59 estimate by 6.60%. Revenue of $487.8 million beat the $478.5 million consensus by 1.94%. Compared with Q2 2025, EPS rose about 19% from $0.53 and revenue rose about 4% from $468.8 million.
Annual EPS in the table fell from $1.67 in 2022 to $1.26 in 2023, then recovered to $1.49 in 2024 and $2.03 in 2025. The first half of 2026 adds up to $1.07, about 24% more than the $0.86 of a year earlier. Revenue has stayed in a narrow band, between $458.4 million and $513.8 million a quarter across the table. Q1 was the weakest quarter of each complete year shown, and the EPS high here is $0.67 in Q3 2025. Pediatrix beat the EPS estimate in 13 of the last 20 quarters, including 7 of the last 8.
Pediatrix reported Q3 between October 28 and November 3 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the year-over-year EPS gains of the first half carry into the third quarter.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | $0.59 | $0.63 | +6.60% | $487.8M | SEC |
| Q1 2026 | May 5, 2026 | $0.38 | $0.44 | +15.85% | $476.2M | SEC |
| Q4 2025 | Feb 19, 2026 | $0.54 | $0.50 | −7.03% | $493.8M | SEC |
| Q3 2025 | Nov 3, 2025 | $0.47 | $0.67 | +43.96% | $492.9M | SEC |
| Q2 2025 | Aug 5, 2025 | $0.42 | $0.53 | +24.74% | $468.8M | SEC |
| Q1 2025 | May 6, 2025 | $0.24 | $0.33 | +36.65% | $458.4M | SEC |
| Q4 2024 | Feb 20, 2025 | $0.37 | $0.51 | +38.81% | $502.4M | SEC |
| Q3 2024 | Nov 1, 2024 | $0.37 | $0.44 | +19.70% | $511.2M | SEC |
| Q2 2024 | Aug 6, 2024 | $0.31 | $0.34 | +8.70% | $504.3M | SEC |
| Q1 2024 | May 7, 2024 | $0.18 | $0.20 | +8.70% | $495.1M | SEC |
| Q4 2023 | Feb 20, 2024 | $0.33 | $0.32 | −1.54% | $496.4M | SEC |
| Q3 2023 | Nov 2, 2023 | $0.44 | $0.32 | −26.44% | $506.6M | SEC |
| Q2 2023 | Aug 3, 2023 | $0.40 | $0.39 | −3.01% | $501.0M | SEC |
| Q1 2023 | May 2, 2023 | $0.23 | $0.23 | +0.48% | $491.0M | SEC |
| Q4 2022 | Feb 17, 2023 | $0.48 | $0.47 | −2.91% | $513.8M | SEC |
| Q3 2022 | Nov 3, 2022 | $0.54 | $0.40 | −26.44% | $489.9M | SEC |
| Q2 2022 | Aug 4, 2022 | $0.47 | $0.47 | −0.49% | $486.0M | SEC |
| Q1 2022 | Apr 28, 2022 | $0.27 | $0.33 | +21.28% | $482.2M | SEC |
| Q4 2021 | Feb 17, 2022 | $0.44 | $0.52 | +19.27% | $498.5M | SEC |
| Q3 2021 | Oct 28, 2021 | $0.41 | $0.46 | +10.87% | $492.9M | SEC |
Quarterly revenue
Frequently asked questions
When did Pediatrix Medical (MD) last report earnings?
Pediatrix Medical last reported on Aug 4, 2026, covering fiscal Q2 2026.
Did MD beat earnings estimates?
Yes. Pediatrix Medical reported EPS of $0.63 for Q2 2026 against a $0.59 estimate — a 6.60% beat.
How much revenue did MD report last quarter?
Pediatrix Medical reported $487.8M in revenue for Q2 2026, against a consensus estimate of $478.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.